Is the Low FODMAP Diet good or bad for our gut bacteria?
As far back as 2012, concerns echoed through scientific corridors about the potential short-term negative impact of the Low FODMAP Diet on our gut bacteria, particularly Bifidobacterium. These concerns lingered for years until a breakthrough study in 2021 by Staudacher et al. brought a sigh of relief, revealing that the feared repercussions on the gut bacteria, specifically Bifidobacterium, did not appear to be a lasting issue.
Bifidobacteria
These bacteria were not affected 1 year after starting the diet as long as patients followed all 3 stages of the low FODMAP diet
The study's comprehensive approach involved patients navigating through 3 crucial phases of the Low FODMAP Diet: elimination, reintroduction, and personalisation. What once raised eyebrows as the "anti-bifidogenic" effects in the early stages of the diet were, in fact, reversed during the 3-stage process. The reintroduction of prebiotic 'fructans' and 'galacto-oligosaccharides' emerged as a likely explanation for this encouraging outcome. These findings underscore the significance of patients diligently adhering to all 3 phases of the diet to maximise its potential benefits and avoid negative effects on their gut bacteria.
The gut is made up of hundreds of different types of gut bacteria
This is often known as ‘bacterial diversity’
While the study alleviated concerns about Bifidobacterium, it did raise new questions about potential reductions in the relative abundance of other bacteria, including Bacteroides and F. prausnitzii, alongside decreased concentrations of short-chain fatty acids crucial for gut health. However, a subsequent study in 2022 by Daniel So and Staudacher offered reassurance. Their research suggested that the short-term impact of the Low FODMAP Diet seemed to be confined to Bifidobacteria, with no lasting repercussions on other critical elements, such as bacterial diversity and short-chain fatty acid concentrations.
Adding another layer to the narrative, a 2022 study led by Kevin Vervier and team delved into the intricate world of gut bacteria in individuals with Irritable Bowel Syndrome (IBS). The study identified two distinct subtypes: one considered 'pathogenic' (IBSP) and the other 'healthy' (IBSH). Strikingly, the pathogenic subtype exhibited unique bacterial species associated with diseases and demonstrated an increased ability to metabolize certain FODMAPs. This metabolic shift was suggested to contribute to heightened gas production in the gut, a key player in IBS symptoms. While the Low FODMAP Diet proved beneficial for 75% of cases, individuals with the pathogenic profile experienced the most significant improvements, with their gut bacteria transitioning towards a 'healthy' profile. A potentially significant benefit of the Low FODMAP Diet…
In summary, while these studies bring hope regarding the Low FODMAP Diet's impact on gut health, it's crucial to note that more research is needed. Nevertheless, while we await new research, these studies are positive and very promising…
References